{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:51:27Z","timestamp":1791697887514,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grants for Emerging Researchers\/Clinicians Mentorship Program (G.E.R.M.) Grant","award":["Grants for Emerging Researchers\/Clinicians Mentorship Program (G.E.R.M.) Grant"],"award-info":[{"award-number":["Grants for Emerging Researchers\/Clinicians Mentorship Program (G.E.R.M.) Grant"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R25DA050985"],"award-info":[{"award-number":["1R25DA050985"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["P30AI027757"],"award-info":[{"award-number":["P30AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Washington Behavioral Research Center for HIV","award":["P30 MH123248"],"award-info":[{"award-number":["P30 MH123248"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10461-023-04110-3","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:12:31Z","timestamp":1687558351000},"page":"3952-3960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Substance Use and Mental Health Comorbidities and Receipt of Specialty Care Among Patients Enrolled in a Low-Barrier HIV Clinic"],"prefix":"10.1007","volume":"27","author":[{"given":"Eden E.","family":"Altwies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin A.","family":"Zinsli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Chwastiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenore P.","family":"Bhatraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena S.","family":"Ramchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"issue":"9738","key":"4110_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","volume":"376","author":"FL Altice","year":"2010","unstructured":"Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367\u201387.","journal-title":"Lancet"},{"issue":"5","key":"4110_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/QAD.0000000000002125","volume":"33","author":"BJ Oldfield","year":"2019","unstructured":"Oldfield BJ, Munoz N, McGovern MP, et al. Integration of care for HIV and opioid use disorder. AIDS. 2019;33(5):873\u201384.","journal-title":"AIDS"},{"issue":"suppl4","key":"4110_CR3","doi-asserted-by":"publisher","first-page":"iv27","DOI":"10.1093\/heapol\/czw169","volume":"32","author":"FLH Chuah","year":"2017","unstructured":"Chuah FLH, Haldane VE, Cervero-Liceras F, et al. Interventions and approaches to integrating HIV and mental health services: a systematic review. Health Policy Plan. 2017;32(suppl4):iv27\u2013iv47.","journal-title":"Health Policy Plan"},{"key":"4110_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03513-4","author":"M Moher","year":"2022","unstructured":"Moher M, Erickson M, Black P, et al. Improving Post-Release Care Engagement for People living with HIV involved in the criminal justice system: a systematic review. AIDS Behav. 2022. https:\/\/doi.org\/10.1007\/s10461-021-03513-4.","journal-title":"AIDS Behav"},{"key":"4110_CR5","doi-asserted-by":"crossref","unstructured":"Holtzman CW, Shea JA, Glanz K Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen\u2019s Behavioral Model. AIDS Care., Hartzler B, Dombrowski JC, Crane HM et al. Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav. 2017; https:\/\/doi.org\/10.1007\/s10461-016-1584-6.","DOI":"10.1007\/s10461-016-1584-6"},{"key":"4110_CR6","doi-asserted-by":"publisher","unstructured":"Hartzler B, Dombrowski JC, Crane HM, et al. Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav. 2017; https:\/\/doi.org\/10.1007\/s10461-016-1584-6","DOI":"10.1007\/s10461-016-1584-6"},{"key":"4110_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0990-0","author":"BR Yehia","year":"2015","unstructured":"Yehia BR, Stewart L, Momplaisir F, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis. 2015. https:\/\/doi.org\/10.1186\/s12879-015-0990-0.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4110_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/apc.2017.0313","volume":"32","author":"JC Dombrowski","year":"2018","unstructured":"Dombrowski JC, Ramchandani M, Dhanireddy S, Harrington RD, Moore A, Golden MR. The Max Clinic: Medical Care designed to engage the hardest-to-Reach Persons living with HIV in Seattle and King County, Washington. AIDS Patient Care STDS. 2018;32(4):149\u201356.","journal-title":"AIDS Patient Care STDS"},{"key":"4110_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac267","author":"MD Hickey","year":"2022","unstructured":"Hickey MD, Imbert E, Appa A, et al. HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People experiencing homelessness. J Infect Dis. 2022. https:\/\/doi.org\/10.1093\/infdis\/jiac267.","journal-title":"J Infect Dis"},{"key":"4110_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/15381501.2017.1407732","author":"K Palar","year":"2018","unstructured":"Palar K, Wong MD, Cunningham WE. Competing subsistence needs are associated with retention in care and detectable viral load among people living with HIV. J HIV AIDS Soc Serv. 2018. https:\/\/doi.org\/10.1080\/15381501.2017.1407732.","journal-title":"J HIV AIDS Soc Serv"},{"key":"4110_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0265-6","author":"MD Wong","year":"2007","unstructured":"Wong MD, Sarkisian CA, Davis C, Kinsler J, Cunningham WE. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007. https:\/\/doi.org\/10.1007\/s11606-007-0265-6.","journal-title":"J Gen Intern Med"},{"key":"4110_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s10461-018-2226-y","volume":"23","author":"B Barker","year":"2019","unstructured":"Barker B, Adams E, Wood E, et al. Engagement in maximally-assisted therapy and adherence to antiretroviral therapy among a cohort of indigenous people who use illicit drugs. AIDS Behav. 2019;23:1258\u201366.","journal-title":"AIDS Behav"},{"issue":"7","key":"4110_CR13","doi-asserted-by":"publisher","first-page":"ofz294","DOI":"10.1093\/ofid\/ofz294","volume":"6","author":"JC Dombrowski","year":"2019","unstructured":"Dombrowski JC, Galagan SR, Ramchandani M, et al. HIV Care for patients with Complex needs: a controlled evaluation of a Walk-In, Incentivized Care Model. Open Forum Infect Dis. 2019;6(7):ofz294.","journal-title":"Open Forum Infect Dis"},{"key":"4110_CR14","doi-asserted-by":"crossref","unstructured":"Imbert E, Hickey MD, Clemenzi-Allen A et al. Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing. AIDS. 2021 Jul 1;35(8):1241\u20131246.","DOI":"10.1097\/QAD.0000000000002843"},{"key":"4110_CR15","unstructured":"2022 Overdose Death Report. In: King County Fatal Overdose Dashboard. Seattle & King County Public Health. 2022. https:\/\/kingcounty.gov\/depts\/health\/overdose-prevention\/~\/media\/depts\/health\/medical-examiner\/documents\/2022-overdose-death-report.ashx."},{"issue":"1","key":"4110_CR16","first-page":"23","volume":"171","author":"JM Pyne","year":"2011","unstructured":"Pyne JM, Fortney JC, Curran GM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011;171(1):23\u201331.","journal-title":"Arch Intern Med"},{"issue":"15","key":"4110_CR17","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1097\/QAD.0000000000000797","volume":"29","author":"BW Pence","year":"2015","unstructured":"Pence BW, Gaynes BN, Adams JL, et al. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS. 2015;29(15):1975\u201386.","journal-title":"AIDS"},{"issue":"Suppl 4","key":"4110_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/508182","volume":"43","author":"LE Sullivan","year":"2006","unstructured":"Sullivan LE, Barry D, Moore BA, et al. A trial of integrated buprenorphine\/naloxone and HIV clinical care. Clin Infect Dis. 2006;43(Suppl 4):184\u201390.","journal-title":"Clin Infect Dis"},{"key":"4110_CR19","doi-asserted-by":"publisher","first-page":"108553","DOI":"10.1016\/j.jsat.2021.108553","volume":"133","author":"A Rosecrans","year":"2022","unstructured":"Rosecrans A, Harris R, Saxton RE, et al. Mobile low-threshold buprenorphine integrated with infectious disease services. J Subst Abuse Treat. 2022;133:108553.","journal-title":"J Subst Abuse Treat"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04110-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-023-04110-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04110-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T13:09:38Z","timestamp":1698152978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-023-04110-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["4110"],"URL":"https:\/\/doi.org\/10.1007\/s10461-023-04110-3","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"3 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and declarations"}},{"value":"Financial interests: JCD has participated in research with materials donated by Hologic, Cepheid and Mayne Pharmaceuticals. MSR is a stockholder at Gilead Sciences and Merck & Co. Non-financial interests: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The University of Washington Human Subjects Division approved this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}